Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot study to assess the potential of oral myofunctional therapy for improving respiration during sleep.

Journal of prosthodontic research·2013
Same author

Multiple ferritins are vital to successful blood feeding and reproduction of the hard tick Haemaphysalis longicornis.

The Journal of experimental biology·2013
Same author

Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.

The British journal of ophthalmology·2013
Same author

Identification and characterization of an interspersed repeat antigen of Babesia microti (BmIRA).

Experimental parasitology·2013
Same author

Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.

Antimicrobial agents and chemotherapy·2013
Same author

[Development of a home care educational program for community physicians and other professionals-a trial in Kashiwa City].

Gan to kagaku ryoho. Cancer & chemotherapy·2012

Related Experiment Video

Updated: Jun 8, 2026

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
04:05

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

A possible mechanism for the decrease in serum thyroxine level by phenobarbital in rodents.

Yoshihisa Kato1, Hiroshi Suzuki, Koichi Haraguchi

  • 1Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki, Kagawa 769-2193, Japan. kato@kph.bunri-u.ac.jp

Toxicology and Applied Pharmacology
|October 12, 2010
PubMed
Summary

Phenobarbital (PB) significantly decreases serum thyroid hormones in mice, hamsters, and rats by increasing liver accumulation of thyroxine (T4). This effect was not observed in guinea pigs, highlighting species-specific responses to PB.

More Related Videos

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice
06:57

Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice

Published on: November 11, 2021

Related Experiment Videos

Last Updated: Jun 8, 2026

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
04:05

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice
06:57

Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice

Published on: November 11, 2021

Area of Science:

  • Pharmacology
  • Endocrinology
  • Toxicology

Background:

  • Phenobarbital (PB) is a widely used drug with known effects on liver enzymes.
  • Thyroid hormones, including thyroxine (T4) and triiodothyronine (T3), are crucial for metabolism and development.
  • Understanding drug-induced alterations in thyroid hormone homeostasis is vital for assessing safety and efficacy.

Purpose of the Study:

  • To investigate the effects of phenobarbital (PB) on serum thyroid hormone levels in various animal models.
  • To elucidate the mechanisms underlying PB-induced changes in thyroid hormone metabolism, focusing on hepatic processes.

Main Methods:

  • Male mice, hamsters, rats, and guinea pigs were administered PB intraperitoneally for 4 days.
  • Serum levels of total T4, free T4, T3, and thyroid-stimulating hormone (TSH) were measured.
  • Hepatic T4-UDP-glucuronosyltransferase (UGT1A) activity and biliary excretion of T4-glucuronide were assessed.
  • In vivo clearance and tissue distribution of radiolabeled T4 were evaluated in PB-pretreated animals.

Main Results:

  • PB administration significantly decreased serum total T4 and free T4 in mice, hamsters, and rats.
  • Serum T3 levels decreased in hamsters and rats, while TSH decreased only in hamsters.
  • PB increased hepatic UGT1A level and activity in mice, hamsters, and rats.
  • PB enhanced T4 clearance from serum and increased T4 accumulation in the liver of mice, rats, and hamsters, but not guinea pigs.

Conclusions:

  • Phenobarbital induces a decrease in serum thyroid hormone levels in rodents primarily through enhanced hepatic uptake and metabolism of T4.
  • The observed effects are species-dependent, with guinea pigs showing a different response pattern.
  • These findings highlight the importance of considering species differences when evaluating the impact of drugs like PB on thyroid function.